VARIABLE EFFECTS OF LEUZEA CARTHAMOIDES (ASTERACEAE) EXTRACTS AND 20-HYDROXYECDYSONE ON NF-KAPPA B
Abstract
Leuzea carthamoides (Willd.) DC. (syn. Rhaponticum carthamoides (Willd.) Iljin, Asteraceae) has adaptogenic [1], anticancer [2] and immunomodulating [3] effects. The plant –traditionally hydroethanolic extracts- and its main ecdysteroid 20-hydroxyecdysone (20-E) are increasingly offered as natural anabolics for animal and human use. Considering the central involvement of the nuclear factor NF-kappa B within the cellular immune response [4] we investigated the effect of pure 20-E and Leuzea extracts using a reporter gene luciferase based model with a transfected HeLa cell line. Cytotoxicity and proliferative effects were controlled by the MTT assay and HPLC fingerprints including 20-E determination recorded. 20-E alone showed a minor inhibitory effect between 5 and 50 ìM upon PMA or TNFá stimulation. In contrast, the stronger effects by standard inhibitors such as parthenolide or dexamethasone were attenuated. Crude hydroethanolic/methanolic herb extracts lowered (IC50 around 20ìg/ml), whereas root extracts increased NF-kappa B activation (plus 50% at 10 ì g/ml). Hydrophilic fractions both from root/herb containing 20-E and higher amounts of phenolcarbonic acids activated, whereas some of the medium polar fractions with higher portion of flavonoids and sesquiterpenlactones inhibited NF-kappa B more effectively (IC50 < 5 ì M). All effects were lowered by the transcription inhibitor dexamethasone. Spiking of the extracts with 20-E attenuated the effect of inhibitors and further increased those of activating extracts in most cases. Leuzea NF-kappa B effects are for the first time reported here. The results show that the standard marker 20-E alone is not primarily responsible, but may modify the effects exhibited by other compounds in either direction. Acknowledgements: A. Kump, Linz (AT) for material provision References: 1Slama et al. (1996) Experientia 52(7):702-6, [2] Hamburger et al. (2006) Planta Med 2006; 72: 992 [3] Kormosh et al.(2006) Phytother Res. 20(5):424-5, [4] Li Q, Verma IM. (2002) Nat Rev Immunol. 2(10):725-34Published
How to Cite
Issue
Section
License
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.